A phase II study of SAR-440340 in Chronic obstructive pulmonary disease (COPD)
Phase of Trial: Phase II
Latest Information Update: 18 Dec 2017
At a glance
- Drugs SAR 440340 (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Proof of concept; Therapeutic Use
- 18 Dec 2017 This study could be initiated alone or in combination with dupilumab.
- 18 Dec 2017 New trial record
- 13 Dec 2017 According to a Sanofi media release, the company expects to initiate this study in 2018.